Objective The objective of this portfolio is to analyze whether Pfizer Inc. is a market leader of producing ethical products in the pharmaceutical industry in Hong Kong. To achieve this objective‚ Pfizer needs to enlarge and rectify their marketing communications‚ (such as‚ adjust their promotional tools‚ differentiate their products...etc). Introduction Pfizer Inc. is established since 1849 by Charles Pfizer and Charles Earhart and up till now‚ it has 150 countries using their pharmaceutical
Premium
Investing helps your assets work for you. What is investing? Investing refers to the act of using your money to buy some sort of financial product or any other item‚ in the hope and expectation that the product will grow in value after you buy it. What are some type of investments? Almost anything you buy now that you think you can sell for more money later is considered an investment‚ including things like real estate‚ collectibles‚ stocks and bonds. So why invest? By investing your money‚ you
Premium Health care Investment
Individual Research Proposal Introduction In this day and age‚ we cannot deny that technology is a key aspect of our daily lives and has definitely made our lives more efficient and convenient in several aspects. 61 million individuals are using mobile phones for health related topics‚ 29 million patients exchange emails with physicians‚ and 9 million consumers use health communities online (Nicole Lucarelli). However‚ many pharmacies are currently not exploiting technology to benefit their companies
Premium Facebook Pharmaceutical industry Social media
BUSINESS DECISION MAKING INTRODUCTION Johnson and Johnson is an American multinational company founded in Brunswick ‚New Jersey in 1886 by American entrepreneur Robert Wood Johnson. It manufactures pharmaceuticals‚ medical devices and consumer products. J&J and its subsidiaries have operations in over 60 countries and sell their products in over 175 countries. Today‚ it employs 120‚000 people worldwide. They are the world’s second largest manufacturer of health care products and
Premium Johnson & Johnson Pharmaceutical industry SWOT analysis
TABLE OF CONTENTS I. INTRODUCTION 1 II. COMPANY HISTORY 1 III. CHIEF EXECUTIVE OFFICER 2 IV. MAJOR PRODUCTS 3 V. MAJOR COMPETITORS 5 VI. SALES HISTORY 6 VII. MAJOR FACTORS AFFECTING INVESTMENT POTENTIAL 7 VIII. STOCK PRICE DATA AND INVESTMENT ANALYSIS 8 IX. CONCLUSIONS & RECOMMENDATIONS 10 EXECUTIVE SUMMARY This company profile provides a preliminary investigation and analysis of Novartis International AG‚ a multinational pharmaceutical company based in Basel‚
Premium Pharmaceutical industry Novartis
Company profile Date of Establishment | 1935 | Revenue | 1386.83 ( USD in Millions ) | Market Cap | 249989.56450195 ( Rs. in Millions ) | Corporate Address | Mumbai Central‚‚Mumbai-400008‚ Maharashtra www.cipla.com | Management Details | Chairperson - Y K Hamied MD - Y K Hamied Directors - Amar Lulla‚ H R Manchanda‚ K A Hamied‚ M K Hamied‚ M R Raghavan‚ Mital Sanghvi‚ Pankaj Patel‚ Ramesh Shroff‚ S A A Pinto‚ S Radhakrishnan‚ V C Kotwal‚ Y K Hamied | Business Operation | Pharmaceuticals &
Premium Executive director Board of directors Managing director
Report on Communication at Mirror Image Commissioned by Tama Wilson‚ CEO of Mirror Image ? ? By Business Consultant Executive summary: Mirror Image needs an overhaul in communication between management and workers. After collecting information collected through the CEO and a resent staff survey‚ it is apparent that certain things are restricting good communication. With the help of great pre-existing research this report identifies several major issues. Distrust of management has led to
Premium Communication
Hitting the Wall: Nike & international labor practices How well and how responsibly do you think she has handled these issues to date? What advice would you give her about how she should now proceed? What principles should guide the company’s policies and practices? What opportunities‚ constraints‚ and risks does the firm face? What are the scope and limits of its social responsibilities? There are two aspects to look at how Nike has acted: 1) The intension with which it has acted:
Premium Social responsibility Corporate social responsibility
[pic] The Pharmaceutical Industry: Challenges in the New Century EMBA City - Group 6 UCD Smurfit School of Business October 2009 Contents |Section | |Content |Page No. | | |Executive Summary |1 | |1. |Macro-environmental factors
Premium Pharmaceutical industry Drug development Generic drug
------------------------------------------------- ------------------------------------------------- BRISTOL-MEYERS SQUIBB FINANCIAL ANALYSIS A BRISTOL MEYERS SQUIBB AMYLIN MERGER ANALYSIS: RICHARD LATIMER UMUC FINANCE MAJOR Executive Summary On August 9th Bristol-Meyers Squibb successfully completed the tender offer for all of the outstanding shares of common stock of Amylin Pharmaceuticals Inc (NASDAQ: AMLN) at a purchase price of $31.00 per share. As of the expiration of the
Premium Revenue Financial ratios Income statement